Human factors research applied: The development of a personal touch screen insulin pump and users' perceptions of actual use

Diabetes Technology and Therapeutics

Volumn 15, Issue 10, 2013, Pages 845-854

  Schaeffer, Noel E ^a  

^a Tandem Diabetes Care Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COMPUTER INTERFACE; HUMAN; HUMAN FACTORS RESEARCH; INSULIN PUMP; PERCEPTION; PRIORITY JOURNAL; QUESTIONNAIRE;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; CALIFORNIA; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; PATIENT SATISFACTION; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; TOUCH; USER-COMPUTER INTERFACE;

EID: 84884583696     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2013.0098     Document Type: Article

References (22)

1. Peyrot M, Rubin RR: Validity and reliability of an instrument for assessing health-related quality of life and treatment preferences: the Insulin Delivery System Rating Questionnaire. Diabetes Care 2005;28:53-58. (Pubitemid 40095782)
2. CDC national diabetes fact sheet. 2011. www.cdc.gov/DIABETES//pubs/pdf/ ndfs-2011.pdf (accessed March 20, 2013).
3. Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan DM, Peterson CM; American Diabetes Association: Tests of glycemia in diabetes. Diabetes Care 2003;26(Suppl 1):S106-S108. (Pubitemid 36928970)
4. Grunberger G, Bailey TS, Cohen AJ, Flood MT, Handelsman Y, Hellman R, Jovanovic L, Moghissi E, Orzeck EA; AACE Insulin Pump Management Task Force: Statement by the American Association of Clinical Endocrinologists Consensus Panel on Insulin Pump Management. Endocr Pract 2010;16:746-762.
5. Pickup J,Keen H: Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 2002;25:593-598.
6. Scheiner G, Sobel RJ, Smith DE, Pick A, Kruger D, King J, Green K: Insulin Pump Therapy: Guidelines for Successful Outcomes. American Association of Diabetes Educators Consensus Summit. Chicago: American Association of Diabetes Educators, 2008.
7. Sanders MS, McCormick EJ: Human Factors in Engineering and Design, 7th ed. New York: McGraw-Hill, 1993.
8. Winslow TF: The Principles of Scientific Management. New York: Harper & Brothers, 1911.
9. Norman D: The Design of Everyday Things. New York: Basic Books, 1988.
10. Gibson JJ: The theory of affordances. In: Shaw R, Bransford J, eds. Perceiving, Acting, and Knowing: Toward an Ecological Psychology. Hillsdale, NJ: Lawrence Erlbaum, 1977:67-82.
11. Kohn LT, Corrigan JM, Donaldson MS, eds. To Err Is Human: Building a Safer Health System. Washington, DC: National Academy Press, 1999.
12. Vincent C: Patient Safety, 2nd ed. Chichester, UK: John Wiley & Sons Ltd., 2010.
13. Food and Drug Administration: Applying human factors and usability engineering to optimize medical device design. www.fda.gov/MedicalDevices/ DeviceRegulationandGuidance/GuidanceDocuments/ucm259748.htm (accessed March 20, 2013).
14. Harris G: FDA orders recall of intravenous pumps. New York Times July 22, 2005.
15. Weinger MB, Wiklund ME, Gardner-Bonneau DJ: Handbook of Human Factors in Medical Device Design. Boca Raton, FL: Taylor & Francis Group, 2011.
16. Tullis T, Albert B: Measuring the User Experience: Collecting, Analyzing, and Presenting Usability Metrics. Amsterdam: Elsevier, 2008.
17. Kuniavsky M: Observing the User Experience: A Practitioner's Guide to User Research. San Francisco: Morgan Kaufmann, 2003.
18. Schaeffer NE: The role of human factors in the design and development of an insulin pump. J Diabetes Sci Technol 2012;6:260-264.
19. Paes AH, Bakker A, Soe-Agnie CJ: Impact of dosage frequency on patient compliance. Diabetes Care 1997;20:1512-1517. (Pubitemid 27415025)
20. Viller F, Guillemin F, Briançon S, Moum T, Suurmeijer T, van den Heuvel W: Compliance to drug treatment of patients with rheumatoid arthritis: a 3 year longitudinal study. J Rheumatol 1999;26:2114-2122. (Pubitemid 29487003)
21. Cramer JA, Gold DT, Silverman SL, Lewiecki EM: A systematic review of persistence and compliance with bisphosphonates for osteoporosis. Osteoporoses Int 2007; 18:1023-1031. (Pubitemid 47019996)
22. Zahn J. D. Analysis: desirable attributes of insulin injection pens that drive patient preference and compliance. J Diabetes Sci Technol 2011;5:1210-1211.